Sutro Biopharma to Participate in Two Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer,...

Click to view original post